Cited by 50Ubiquitin and proteasome pathwaysParkinson's Disease Mechanisms and TreatmentsTGF-β signaling in diseases

TGF-β 1 enhances neurite outgrowth via regulation of proteasome function and EFABP

Open access
Knöferle, Johanna, Ramljak, Sanja, Koch, Jan C., Tönges, Lars, Asif, Abdul R., Michel, Uwe, Wouters, Fred S., Heermann, Stephan +4 more·2010·Neurobiology of Disease

Abstract

Malfunction of the ubiquitin-proteasome system has been implicated as a causal factor in the pathogenesis of aggregation-related disorders, e.g. Parkinson's disease. We show here that Transforming growth factor-beta 1 (TGF-beta), a multifunctional cytokine and trophic factor for dopaminergic (DAergic) neurons modulates proteasome function in primary midbrain neurons. TGF-beta differentially inhibited proteasomal subactivities with a most pronounced time-dependent inhibition of the peptidyl-glutamyl peptide hydrolyzing-like and chymotrypsin-like subactivity. Regulation of proteasomal activity could be specifically quantified in the DAergic subpopulation. Protein blot analysis revealed an accumulation of ubiquitinated proteins after TGF-beta treatment. The identity of these enriched proteins was further analyzed by 2D-gel electrophoresis and mass spectrometry. We found epidermal fatty acid binding protein (EFABP) to be strongly increased and ubiquitinated after TGF-beta treatment and confirmed this finding by co-immunoprecipitation. While application of TGF-beta increased neurite regeneration in a scratch lesion model, downregulation of EFABP by siRNA significantly decreased this effect. We thus postulate that a differential regulation of proteasomal function, as demonstrated for TGF-beta, can result in an enrichment of proteins, such as EFABP, that mediate physiological functions, such as neurite regeneration.

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2010.02.011

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Activation of Smad2 signaling has also been reported to occur with myelin axonal growth inhibition, and direct activation of Smad2 reduces axonal outgrowth in some preparations.

    “However, activation of Smad2 signaling has also been reported to occur with myelin axonal growth inhibition, and direct activation of Smad2 reduces axonal outgrowth in some preparations22,24.”
  • In other in vitro systems, TGFβ promotes axonal outgrowth of injured neurons and blockade of TGFβRII alters neuronal polarity and leads to shorter axons.

    “In other in vitro systems, TGFβ promotes axonal outgrowth of injured neurons21,22,39,40 and blockade of TGFβRII alters neuronal polarity and leads to shorter axons42.”

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 55 · Cited by 50

Authors
Knöferle, J., Ramljak, S., Koch, J. C., Tönges, L., Asif, A. R., Michel, U., Wouters, F. S., Heermann, S., Krieglstein, K., Zerr, I., Bähr, M., & Lingor, P.
Affiliations
  • Universitätsmedizin Göttingen (DE)
  • University of Göttingen (DE)
  • University of Freiburg (DE)
Corresponding author
Lingor, Paul
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2010-06
Volume
38
Issue
3
Pages
395-404
ISSN
0969-9961 (ISSN-L)
OpenAlex
W2024385705
Cited by
50
References
55
Citations by year
2026: 1 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 6 · 2017: 5 · 2016: 1 · 2015: 7 · 2014: 5 · 2013: 3 · 2012: 1
FWCI
0.91
Type
journal article
Language
en
Open access
Locations
  • Neurobiology of Disease (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Repository of Futwangen University of Applied Sciences (Furtwangen University) (submittedVersion)
  • GRO (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
TGF-β1, neurite outgrowth, proteasome function, ubiquitin-proteasome system, epidermal fatty acid binding protein, dopaminergic neurons, midbrain neurons, ubiquitinated proteins, chymotrypsin-like activity, neurite regeneration, Parkinson's disease
MeSH terms
Animals, Cells, Cultured, Dopamine, Eye Proteins, Hydrolysis, Mesencephalon, Nerve Regeneration, Nerve Tissue Proteins, Neurons, Time Factors, Neurites, Rats, Wistar, Proteasome Endopeptidase Complex, Cell Enlargement, Fatty Acid-Binding Proteins, Rats, Transforming Growth Factor beta1, Ubiquitination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review